Expiration Date: 05/06/2025
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Speakers
Anthony Jaworski, PharmD, BCCCP, DABAT
Clinical Program Manager - Poison Control
Children’s Hospital of Philadelphia
Liz Laubach, PharmD, BCPS, DABAT
Assistant Professor of Toxicology
Concordia University Wisconsin School of Pharmacy/Wisconsin Poison Center
Moderator:
Alexandra Funk, PharmD, DABAT
Managing Director
Florida Poison Information Center - Tampa
Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Has disclosed no relevant financial relationships
Description
Drs. Laubach and Jaworski will discuss the following articles:
• Freund Y, Viglino D, Cachanado M, et al. Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial. JAMA. 2023 Dec 19;330(23):2267-2274. doi: 10.1001/jama.2023.24391. PMID: 38019968; PMCID: PMC10687712
• Michael Levine, Jeffrey Brent, Timothy Wiegand, Bryan Maguire, Neta Cohen, David Vaerrier, Michael Beuhler, Jerrold B. Leikin, Michael Ganetsky, Samuel Stellpflug, Anne-Michelle Ruha, Jennifer Carey, Ann-Jeannette Geib, Dazhe James Cao, Kurt Kleinschmidt, Rais Vohra, Brad D. Riley, Phillip Moore, Evan Schwarz, Mark Neavyn, Daniel E. Rusyniak, Spencer Greene, Joshua Nogar, Alex Manini, Mary Wermuth, Anthony Pizon, Robert G. Hendrickson, Matthew Griswold, Kim Aldy, Paul Wax, Meghan Beth Spyres, Sharan Campleman, Erin Macdonald, Yaron Finkelstein & on behalf of the Toxicology Investigators Consortium (2023) Lipid emulsion therapy during management of the critically ill poisoned patient: a prospective cohort study, Clinical Toxicology, 61:8, 584-590, DOI: 10.1080/15563650.2023.2248372
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives - After attending this program you should be able to:
- Review existing literature exploring airway management for comatose individuals.
- Critically evaluate the most study investigating airway management in comatose patients with acute poisoning.
- Review the existing literature that addresses the use of the partition coefficient (LogP) of intoxicants to guide the use of intravenous lipid emulsion therapy in poisoned patients.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.
Click here to complete the Post Webinar CE Evaluation